期刊文献+

儿童免疫性血小板减少症生活质量 被引量:14

Research on quality of life in children with immune thrombocytopenia
原文传递
导出
摘要 免疫性血小板减少症(ITP)是儿童常见的出血性疾病。因为血小板减少、出血、疾病预后、治疗的不良反应、活动受限等问题,常导致患儿及父母的生活质量显著降低。现就国内外儿童ITP的生活质量作一述评,以引起更多关注和重视。在ITP治疗抉择和管理时,应将健康相关的生活质量作为重要参考指标之一。 Immune thrombocytopenia (ITP) is a common bleeding disease in children. Recent advances has indicated that such factors as decreased platelet, fear of bleeding, prognosis, therapy associated side effect and restricted activities, usually decreased quality of life of patients and their parents. This review focuses on domestic and overseas re- searches on health -related quality of life (HRQoL) in children with ITP,in order to attract more scholars' attention. HRQoL should be recommended as an important indicator in treatment and management of ITP.
作者 周敏 徐倩
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2017年第15期1132-1136,共5页 Chinese Journal of Applied Clinical Pediatrics
基金 成都市卫计委科研项目(2015068) 成都市科技局科研项目(2015-HM01-00568-SF)
关键词 免疫性血小板减少症 生活质量 儿童免疫性血小板减少症评估量表 儿童 hnmune thrombocytopenia Quality of life The kids' immune thrombocytopenia tools Child
  • 相关文献

参考文献3

二级参考文献30

  • 1COOPER N, BUSSEL J. The pathogenesis of immune thrombocytopaenic purpura[J]. Br J Haematol, 2006,133:364-374.
  • 2BARNARD D, WOLOSKI M, FEENY D, et al. Development of disease-specific health-related quality-of- life instruments for children with immune thrombocytopenic purpura and their parents[J]. J Pediatr Hematol Oncol, 2003,25:56-62.
  • 3LI L, WANG H M, SHEN Y. Chinese SF-36 health survey: Translation, cultural adaptation, validation, and normalisation [ J ]. J Epidemiol Community Health, 2003,57:259-263.
  • 4KOH ET, LEONGKP, TSOUIY, etal. The reli- ability, validity and sensitivity to change of the chi nese version of SF-36 in oriental patients with rheu matoid arthritis [ J]. Rheumatology (Oxford), 2006, 45:1023-1028.
  • 5GOMEZ-BESTEIRO M I, SANTIAGO-PEREZ M I, ALONSO-HERNANDEZ A, et al. Validity and reli ability of the SF-36 questionnaire in patients on the waiting list for a kidney transplant and transplant patients[J]. AmJ Nephrol, 2004,24:346-351.
  • 6THUMBOO J, FONG K Y, MACHIN D, et al. A community-based study of scaling assumptions and construct validity of the english(uk) and chinese(hk) SF-36 in singapore[J]. Qual Life Res, 2001,10: 175-188.
  • 7FAILDE I, RAMOS I. Validity and reliability of the SF-36 health survey questionnaire in patients with coronary artery disease[J]. J Clin Epidemiol, 2000, 53:359-365.
  • 8WARE J E, SNOW K K, KOSINSKI M, et al. SF-36 health survey.. Manual and interpretation guide [M]. Boston MA.. The Health Institute, New England Medical Center, 1993:465-470.
  • 9BUCHANAN G R, ADIX L. Outcome measures and treatment endpoints other than platelet count in child- hood idiopathic thrombocytopenic purpura[J]. Semin Thromb Hemost, 2001,27:277-285.
  • 10BUCHANAN G R, ADIX L. Current challenges in the management of children with idiopathic thrombo- cytopenic purpura[J]. Pediatr Blood Cancer, 2006, 47:681-684.

共引文献18

同被引文献85

引证文献14

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部